Page last updated: 2024-09-04

levofloxacin and Flavobacteriaceae Infections

levofloxacin has been researched along with Flavobacteriaceae Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aslan, S; Aykent, A; Ignak, S; Karadağ, G; Soydan, S; Unay Demirel, O1
Chan, YJ; Huang, YC; Huang, YW; Lin, YT; Wang, FD; Yang, TC1
Hung, PP; Lin, CF; Lin, YH; Liu, MF; Shi, ZY1

Other Studies

3 other study(ies) available for levofloxacin and Flavobacteriaceae Infections

ArticleYear
Chryseobacterium indolegenes infection in a patient with chronic obstructive pulmonary disease.
    Drug discoveries & therapeutics, 2017, Jul-31, Volume: 11, Issue:3

    Topics: Aged; Anti-Bacterial Agents; C-Reactive Protein; Chryseobacterium; Culture Techniques; Flavobacteriaceae Infections; Humans; Levofloxacin; Male; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Sputum

2017
Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017, Volume: 36, Issue:8

    Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; Chryseobacterium; Drug Resistance, Bacterial; Female; Flavobacteriaceae Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Survival Analysis; Taiwan; Treatment Outcome

2017
Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2008, Volume: 41, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Chryseobacterium; Ciprofloxacin; Female; Flavobacteriaceae Infections; Humans; Infant; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome

2008